Evidence map›Paper›PMID 30042928›Full record

ArticleFrontiers in cellular and infection microbiology2018

Molecular Characterization of

Daniel P Duarte, Éden R Ferreira, Fabio M Lima, Franciane Batista, Michel De Groote, Eduardo Horjales, Luiz C Miletti, Diana Bahia

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Frontiers in cellular and infection microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Daniel P DuarteLaboratório de Bioquímica de Hemoparasitas e Vetores-Centro de Ciências Agroveterinárias, Universidade do Estado de Santa Catarina, Lages, Brazil.
Éden R FerreiraDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Fabio M LimaDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Franciane BatistaLaboratório de Bioquímica de Hemoparasitas e Vetores-Centro de Ciências Agroveterinárias, Universidade do Estado de Santa Catarina, Lages, Brazil.
Michel De GrooteInstituto de Física de São Carlos, Universidade de São Paulo, São Carlos, Brazil.
Eduardo HorjalesInstituto de Física de São Carlos, Universidade de São Paulo, São Carlos, Brazil.
Luiz C MilettiLaboratório de Bioquímica de Hemoparasitas e Vetores-Centro de Ciências Agroveterinárias, Universidade do Estado de Santa Catarina, Lages, Brazil.
Diana BahiaDepartamento de Biologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Universidade do Estado de Santa Catarina · BRUniversidade de São Paulo · BRUniversidade Federal de São Paulo · BRUniversidade Federal de Minas Gerais · BR

Funding

Doc Sherlock: An Autonomous Relay Agent for Discovering the "Unknown Knowns" in Precision MedicineOT2TR003435 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BYRD, WILLIAM E, MIGHT, MATTHEW BRENDON · 2020 to 2024
$4.9M
NCATS NIH HHS OT2 TR003435
6 · The paper itself

Abstract

The mevalonate pathway is an essential part of isoprenoid biosynthesis leading to production of a diverse class of >30,000 biomolecules including cholesterol, heme, and all steroid hormones. In trypanosomatids, the mevalonate pathway also generates dolichols, which play an essential role in construction of glycosylphosphatidylinositol (GPI) molecules that anchor variable surface proteins (VSGs) to the plasma membrane. Isoprenoid biosynthesis involves one of the most highly regulated enzymes in nature, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), which catalyzes the conversion of HMG-CoA to mevalonic acid. The enzyme mevalonate kinase (MVK) subsequently converts mevalonic acid to 5-phosphomevalonic acid.

Indexed as

Gene Expression ProfilingMevalonic AcidMicrobodiesMolecular WeightPhosphotransferases (Alcohol Group Acceptor)Protein MultimerizationTrypanosomamevalonate kinaseMevalonic Acidphosphomevalonic acidPhosphotransferases (Alcohol Group Acceptor)3-hydroxy-3-methylglutaryl-CoA reductaseenzyme activitymevalonate kinaseSurraTrypanosoma evansi

Identifiers

PMID30042928
PMCPMC6048237
OpenAlexW2867370330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.